GlassScriptPhysician profile
William L Schoolmeester
NPI 1104858950
$6,067.41
in general payments reported to CMS, 2019-2025
37 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $746 · 2021: $1,193 · 2022: $962 · 2023: $1,227 · 2024: $702 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $822.32 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $528.27 | 2021-2025 | Verquvo |
| Amgen INC. | $425.64 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $366.87 | 2019-2023 | Xarelto |
| Pfizer INC. | $315.47 | 2019-2024 | |
| Biotronik INC. | $306.68 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.48 | 2019-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $280.11 | 2019-2023 | Lifevest |
| Abbott Laboratories | $262.25 | 2019-2024 | Mitraclip, Aveir |
| E.R. Squibb & Sons, L.L.C. | $240.54 | 2020-2024 | Camzyos |
| Vital Connect, INC | $233.93 | 2023-2024 | Vitalpatch Rtm |
| Astellas Pharma US INC | $153.45 | 2019-2023 | Lexiscan |
| Sanofi-Aventis U.S. LLC | $148.16 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $146.14 | 2019-2025 | Praluent, Evkeeza |
| Esperion Therapeutics, INC. | $143.67 | 2020-2023 | Nexletol |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $139.58 | 2019-2024 | |
| Medicomp INC | $136.72 | 2019-2023 | Telepatch Cardiac Monitor |
| Amryt Pharma Holdings LTD | $132.24 | 2021-2023 | Juxtapid |
| Cvrx, INC. | $111.41 | 2023-2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $96.38 | 2021-2024 | Farxiga |
| Amarin Pharma, INC. | $95.99 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $94.39 | 2023-2024 | Inpefa |
| Lundbeck LLC | $91.64 | 2019-2021 | |
| Medtronic, INC. | $63.08 | 2021-2023 | Mycarelink |
| Actelion Pharmaceuticals US, INC. | $61.09 | 2020-2024 | Opsumit, Uptravi |
| Corvista Health, INC. | $53.35 | 2025 | Corvista System |
| Alnylam Pharmaceuticals INC. | $43.98 | 2023 | Onpattro |
| Medtronic Vascular, INC. | $42.12 | 2019 | |
| Jazz Pharmaceuticals INC. | $40.04 | 2019-2020 | |
| Baxter Healthcare | $33.21 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $32.79 | 2022-2023 | Injectafer |
| Chiesi USA, INC. | $31.22 | 2024-2025 | Juxtapid |
| Bayer Healthcare Pharmaceuticals INC. | $29.43 | 2023-2024 | |
| G Medical Diagnostic Services, INC. | $28.72 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $20.77 | 2024 | Assure Wcd |
| Itamar Medical INC | $19.28 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $14.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schoolmeester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.